tirz vs semaglutide Tirzepatide and key differences, weight loss results (2026) Cardiovascular outcomes of semaglutide and

The study, along with prior research and cardiovascular trials, suggests that GLP1 receptor agonists may offer a broad survival benefit through combined cardiometabolic and cellular effects

J Med Biochem

However, since Saxenda (liraglutide) became the first GLP-1 approved for weight loss in 2014, additional options like Wegovy (semaglutide) and Zepbound (tirzepatide) have also been approved for weight management

Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study